Literature DB >> 22790384

Immunoregulatory function of IL-27 and TGF-β1 in cardiac allograft transplantation.

Laetitia Le Texier1, Pamela Thebault, Manuela Carvalho-Gaspar, Virginie Vignard, Emmanuel Merieau, Claire Usal, Maria-Cristina Cuturi, Kathryn J Wood, Elise Chiffoleau.   

Abstract

BACKGROUND: Deciphering the mechanisms of tolerance represents a crucial aim of research in transplantation. We previously identified by DNA chip interleukin (IL)-27 p28 and transforming growth factor (TGF)-β1 as overexpressed in a model of rat cardiac allograft tolerance mediated by regulatory CD4CD25 T cells. The role of these two molecules on the control of the inflammatory response remains controversial. However, both are involved in the regulation of the T helper 17/Treg axis, suggesting their involvement in tolerance.
METHODS: We analyzed regulation of IL-27 and TGF-β1 expression in allograft response and their role in tolerance by using blocking anti-TGF-β antibody and by generating an adeno-associated virus encoding IL-27.
RESULTS: Here, we confirmed the overexpression of IL-27 and TGF-β1 in tolerated cardiac allografts in two different rodent models. We observed that their expression correlates with inhibition of T helper 17 differentiation and with expansion of regulatory CD4CD25 T cells. We showed in a rat model that anti-TGF-β treatment abrogates infectious tolerance mediated by the transfer of regulatory CD4CD25 T cells. Moreover, overexpression of IL-27 by adeno-associated virus administration in combination with a short-term immunosuppression allows prolongation of cardiac allograft survival and one tolerant recipient. We found that IL-27 overexpression did not induce Foxp3CD4CD25 T-cell expansion but rather IL-10-expressing CD4 T cells in the tolerant recipient.
CONCLUSIONS: Taken together, these data suggest that both TGF-β1 and IL-27 play a role in the mechanisms of tolerance. However, in contrast to TGF-β1, IL-27 seems not to be involved in regulatory CD4CD25 T-cell expansion but rather in their mode of action.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22790384      PMCID: PMC3442234          DOI: 10.1097/TP.0b013e31825b0c38

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  49 in total

1.  IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells.

Authors:  Cheryl M Sweeney; Roisin Lonergan; Sharee A Basdeo; Katie Kinsella; Lara S Dungan; Sarah C Higgins; Patrick J Kelly; Lisa Costelloe; Niall Tubridy; Kingston H G Mills; Jean M Fletcher
Journal:  Brain Behav Immun       Date:  2011-03-21       Impact factor: 7.217

2.  Evidence for immune regulation in the induction of transplantation tolerance: a conditional but limited role for IL-4.

Authors:  A Bushell; M Niimi; P J Morris; K J Wood
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

3.  Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection.

Authors:  R J Corry; H J Winn; P S Russell
Journal:  Transplantation       Date:  1973-10       Impact factor: 4.939

4.  Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system.

Authors:  Jason S Stumhofer; Arian Laurence; Emma H Wilson; Elaine Huang; Cristina M Tato; Leanne M Johnson; Alejandro V Villarino; Qiulong Huang; Akihiko Yoshimura; David Sehy; Christiaan J M Saris; John J O'Shea; Lothar Hennighausen; Matthias Ernst; Christopher A Hunter
Journal:  Nat Immunol       Date:  2006-08-13       Impact factor: 25.606

5.  Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells.

Authors:  Denise C Fitzgerald; Guang-Xian Zhang; Mohamed El-Behi; Zoë Fonseca-Kelly; Hongmei Li; Shuo Yu; Christiaan J M Saris; Bruno Gran; Bogoljub Ciric; Abdolmohamad Rostami
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

6.  Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10.

Authors:  Jason S Stumhofer; Jonathan S Silver; Arian Laurence; Paige M Porrett; Tajie H Harris; Laurence A Turka; Matthias Ernst; Christiaan J M Saris; John J O'Shea; Christopher A Hunter
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

7.  Indirect CD4+ TH1 response, antidonor antibodies and diffuse C4d graft deposits in long-term recipients conditioned by donor antigens priming.

Authors:  C Ballet; K Renaudin; N Degauque; H L Mai; F Boëffard; D Lair; L Berthelot; C Feng; H Smit; C Usal; M Heslan; R Josien; S Brouard; J-P Soulillou
Journal:  Am J Transplant       Date:  2009-04       Impact factor: 8.086

8.  Role of IFNgamma in allograft tolerance mediated by CD4+CD25+ regulatory T cells by induction of IDO in endothelial cells.

Authors:  P Thebault; T Condamine; M Heslan; M Hill; I Bernard; A Saoudi; R Josien; I Anegon; M C Cuturi; E Chiffoleau
Journal:  Am J Transplant       Date:  2007-09-14       Impact factor: 8.086

9.  Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy.

Authors:  Guang-Ping Gao; Mauricio R Alvira; Lili Wang; Roberto Calcedo; Julie Johnston; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-21       Impact factor: 11.205

10.  Induction of Fractalkine and CX3CR1 mediated by host CD8+ T cells in allograft tolerance induced by donor specific blood transfusion.

Authors:  Cédric Louvet; Jean-Marie Heslan; Emmanuel Merieau; Jean-Paul Soulillou; Maria-Cristina Cuturi; Elise Chiffoleau
Journal:  Transplantation       Date:  2004-11-15       Impact factor: 4.939

View more
  7 in total

1.  IL-34 is a Treg-specific cytokine and mediates transplant tolerance.

Authors:  Séverine Bézie; Elodie Picarda; Jason Ossart; Laurent Tesson; Claire Usal; Karine Renaudin; Ignacio Anegon; Carole Guillonneau
Journal:  J Clin Invest       Date:  2015-09-21       Impact factor: 14.808

Review 2.  Regulator Versus Effector Paradigm: Interleukin-10 as Indicator of the Switching Response.

Authors:  Ervin Ç Mingomataj; Alketa H Bakiri
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

Review 3.  Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?

Authors:  Eros Marín; Maria Cristina Cuturi; Aurélie Moreau
Journal:  Front Immunol       Date:  2018-02-19       Impact factor: 7.561

Review 4.  Transplant Tolerance, Not Only Clonal Deletion.

Authors:  Bruce M Hall; Nirupama D Verma; Giang T Tran; Suzanne J Hodgkinson
Journal:  Front Immunol       Date:  2022-04-21       Impact factor: 8.786

5.  Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance.

Authors:  Patricia E de Almeida; Everett H Meyer; Nigel G Kooreman; Sebastian Diecke; Devaveena Dey; Veronica Sanchez-Freire; Shijun Hu; Antje Ebert; Justin Odegaard; Nicholas M Mordwinkin; Thomas P Brouwer; David Lo; Daniel T Montoro; Michael T Longaker; Robert S Negrin; Joseph C Wu
Journal:  Nat Commun       Date:  2014-05-30       Impact factor: 14.919

6.  IL-27 Rα+ cells promoted allorejection via enhancing STAT1/3/5 phosphorylation.

Authors:  Shanshan Zhao; Ting Liang; Chao Zhang; Dai Shi; Wen Jiang; Chen Su; Guihua Hou
Journal:  J Cell Mol Med       Date:  2020-08-06       Impact factor: 5.310

Review 7.  Tolerogenic Dendritic Cells: The Pearl of Immunotherapy in Organ Transplantation.

Authors:  Quan Zhuang; Haozheng Cai; Qingtai Cao; Zixin Li; Shu Liu; Yingzi Ming
Journal:  Front Immunol       Date:  2020-10-06       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.